Skip to main content

Table 3 Comparison of parameters among patients with different responses

From: Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Parameters All patients Responders Non-responders P value
SUVP* 5.51 ± 2.50 4.61 ± 1.94 6.55 ± 2.74 0.039
SUVLN 3.47 ± 1.71 3.59 ± 1.81 3.33 ± 1.65 0.699
T/LN 2.04 ± 2.30 1.42 ± 0.53 2.75 ± 3.25 0.172
TBRP* 7.73 ± 6.09 5.34 ± 3.03 10.49 ± 7.58 0.023
TBRLN 4.43 ± 2.31 4.20 ± 2.53 4.68 ± 2.11 0.589
D* 1.41 ± 2.0 2.78 ± 1.37 -0.16 ± 1.33  < 0.001
  1. D changes of tumor diameter before and after treatment
  2. *P < 0.05